LDN and Fibromyalgia

In 2009, Stanford University conducted a pilot study to test how effective LDN is at treating musculoskeletal pain, sensitivity to mechanical stimulation, and other fibromyalgia symptoms. The researchers found that LDN use led to a reduction of one-third in the severity of symptoms compared to a placebo, and side effects were rare.

In 2013, another follow-up study at Stanford University tested LDN as a treatment for fibromyalgia. Again, LDN was shown to reduce pain significantly. Participants in this study also reported the secondary benefits of less fatigue, improved sleep, and a generally more positive, optimistic outlook on life.

In 2014, a SUNY Upstate Medical University retrospective study reported that LDN improved pain tolerance for fibromyalgia patients.

Stanford University performed yet another study on LDN in 2016 – this one funded by the National Institutes of Health (NIH) – and focusing on chronic pain syndromes, including fibromyalgia. In this study, fibromyalgia patients experienced significant relief with minimal adverse side effects. In addition to fibromyalgia, LDN proved to be a potent remedy for other pain conditions such as migraine headaches and interstitial cystitis (a painful bladder syndrome).

LDN shows signs of being a safe and promising candidate for treating fibromyalgia and is already being prescribed by hundreds of physicians worldwide for this chronic and painful condition.